HGS Execs Hid Lupus Drug's Suicide Link: Suit
A Human Genome Sciences Inc. shareholder lodged a derivative complaint Wednesday against the biotech company's CEO and several other officers and directors, alleging they hid from investors the fact that lupus...To view the full article, register now.
Already a subscriber? Click here to view full article